(Q45133928)

9 December 2017

Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma (English)

1 reference

9 December 2017

1 reference

6

1 reference

9 December 2017

7

1 reference

9 December 2017

S R Grobmyer

1

1 reference

9 December 2017

R G Maki

2

1 reference

9 December 2017

G D Demetri

3

1 reference

9 December 2017

M Mazumdar

4

1 reference

9 December 2017

E Riedel

5

1 reference

9 December 2017

1 November 2004

1 reference

9 December 2017

1 reference

9 December 2017

15

1 reference

9 December 2017

1667-1672

1 reference

9 December 2017

11

1 reference

Management of soft-tissue sarcomas: an overview and update

9 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

Predictive variables detailing the recurrence rate of soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

Adjuvant chemotherapy of soft tissue sarcoma-current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

Ifosfamide in the adjuvant therapy of soft tissue sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDH431

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDH431

1 reference

9 December 2017

1 reference